NantKwest's IPO

NantKwest raised a round of funding on July 28, 2015. Investors include Public.

NantKwest (NASDAQ: NK), formerly Conkwest, is a life sciences company that is developing and commercializing a robust product pipeline for the treatment of cancers and viral infections. The company's …

Articles about NantKwest's IPO: